completion of other formalities. In a contempt petition filed by the Petitioner, PCI’s counsel informed the Court that approval had been granted vide communication dated 05.11.2025 for academic session 2025-26. The Court directed to upload the order on the website forthwith and contempt petition was withdrawn. Therefore, Petitioner is now entitled to apply for approval of M. Pharm and Pharm D. courses for academic session 2026-27. 8. Learned counsel further submits that since the last date of 31.10.2025 for submitting applications for extension of approval for academic session 2026-27 was approaching and Petitioner had approval for D. Pharm and B. Pharm courses, as per approval letter dated 28.08.2025, Petitioner could only submit its application for the said courses and not for M. Pharm and Pharm D. courses. To avoid any complexity, Petitioner proceeded to submit the application for existing approved D. Pharm and B. Pharm courses. Although, PCI’s portal permitted the Petitioner to apply for extension of the existing courses, it did not permit the Petitioner for the M. Pharm and Pharm D. courses, as at that stage approval was pending for the academic session 2025-26 at the end of PCI, however, now that Petitioner has successfully obtained the said approval, it should not be deprived of the benefits of the fruits of the earlier litigation. In this background, it is urged that direction be issued to PCI to activate the portal in respect of M. Pharm and Pharm D. courses and enable the Petitioner to submit the application for academic session 2026-27 in respect of M. Pharm and Pharm D. courses.